World Health Organization– tag –
-
Business Trends
FDA Clears Dexcom’s Stelo, First Over-the-Counter CGM for Non-Insulin-Using Children Aged Two and Older
FDA USA Overview The U.S. FDA has approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged two and older who do not use insulin. This expansion significantly ... -
Market Trends
FDA Clears Dexcom Stelo: First Over-the-Counter Continuous Glucose Monitor to Transform Non-Insulin-Dependent Diabetes Management
U.S. Food and Drug Administration (FDA) News Release USA Overview The U.S. FDA has cleared the Dexcom Stelo Glucose Biosensor System, the first over-the-counter (OTC) continuous glucose monitor (CGM) for individuals aged 18 and older not...